Decreased Leukotriene Production [PE] - N0000008683

Pharmacologic Class Information

Pharmacologic Code N0000008683
Pharmacologic Name Decreased Leukotriene Production
Pharmacologic Uses
  • 5-lipoxygenase inhibitor
Pharmacologic Concept Physiologic Effects - [PE]
Pharmacologic Concept Description This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

NDC Products with Decreased Leukotriene Production

The following table contains 7 products whose active ingredient are classified under the same pharmacologic class Decreased Leukotriene Production [PE].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
10122-901Zyflo Non-Proprietary Name: ZileutonTabletOralChiesi Usa, Inc.ACTIVE
31722-044Zileuton Non-Proprietary Name: ZileutonTablet, Film Coated, Extended ReleaseOralCamber Pharmaceuticals, Inc.ACTIVE
49884-723Zileuton Non-Proprietary Name: ZileutonTablet, Multilayer, Extended ReleaseOralPar Pharmaceutical, Inc.ACTIVE
64380-189Zileuton Non-Proprietary Name: ZileutonTablet, Multilayer, Extended ReleaseOralStrides Pharma Science LimitedACTIVE
64980-206Zileuton Non-Proprietary Name: ZileutonTablet, Extended ReleaseOralRising Pharmaceuticals, Inc.ACTIVE
66993-485Zileuton Non-Proprietary Name: ZileutonTablet, Extended ReleaseOralPrasco, LlcACTIVE
69339-130Zileuton Non-Proprietary Name: ZileutonTablet, Multilayer, Extended ReleaseOralDash Pharmaceutical LlcACTIVE